Development and Validation of a Chemotherapy-Induced Taste Alteration Scale

Kano, Tadashige; Kanda, Kiyoko

doi:10.1188/13.onf.e79-e85

Cited by 73 publications

(85 citation statements)

References 15 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Most questions were based on the English version of a validated chemotherapy-induced taste alteration scale (CiTas) (12). The scale of the Japanese CiTas appeared not to be appropriate for the Dutch population, since no appropriate translation of the English grading (no, slightly, somewhat, quite, and very) could be established.…”

Section: Questionnairementioning

confidence: 99%

Metallic Taste in Cancer Patients Treated with Systemic Therapy: A Questionnaire-based Study

IJpma

Timmermans

Renken

et al. 2016

Nutrition and Cancer

View full text Add to dashboard Cite

A metallic taste is reported by cancer patients as a side effect of systemic therapy. Despite the high prevalence, this taste alteration has received limited attention. The present study investigated: 1) the prevalence of metallic taste in cancer patients treated with systemic therapy; 2) possible predictors of metallic taste; and 3) characteristics of metallic taste. A heterogeneous population of 127 cancer patients, who had received systemic treatment in the past year or were still on treatment, completed a questionnaire developed for this study. Fifty-eight of 127 (46%) patients reported taste changes in the preceding week. Of these patients, 20 (34%) reported a metallic taste. Patients treated with chemotherapy, concomitant radiotherapy, as well as targeted therapy reported metallic taste. Women experienced metallic taste more often than men. Patients experiencing a metallic taste also reported more frequently that they were bothered by sour food and that everything tasted bitter. The experience of metallic taste was highly variable among patients. In conclusion, metallic taste is a frequently experienced taste alteration by cancer patients. Patients treated with chemotherapy, concomitant radiotherapy, and targeted therapy are all at risk for this taste alteration. However, not all patients reported this alteration as bothersome.

show abstract

Section: Questionnairementioning

confidence: 99%

Metallic Taste in Cancer Patients Treated with Systemic Therapy: A Questionnaire-based Study

IJpma

Timmermans

Renken

et al. 2016

Nutrition and Cancer

View full text Add to dashboard Cite

show abstract

“…Hypogeusia: decline in taste sensitivity, Ageusia: complete lack of taste functions of the tongue, Parageusia: perversion of the sense of taste, Cacogeusia: unpleasant taste that does not originate from food or beverage, Phantogeusia (taste hallucination): continuous abnormal taste in the mouth, usu ally bitter or metallic, and Hypergeusia: increase in taste sensitivity (6)(7)(8).…”

Section: Introductionmentioning

confidence: 99%

Taste Alteration in Patients Receiving Chemotherapy

Sözeri

Kutlutürkan

2015

J Breasth Health

View full text Add to dashboard Cite

Objective: This study is aimed to determine factors that affect conditions of patients receiving chemotherapy in terms of experienced taste alteration. Materials and Methods:In this descriptive study, 184 patients receiving chemotherapy were included in the sample. Data were collected during the period of December 2013 to May 2014 using "Patient Characteristics Identification Form" and "Chemotherapy-induced Taste Alteration Scale (CiTAS)." The data were analyzed using SPSS 20 (SPSS Inc., Chicago IL, USA) statistical software in terms of number, percentage, Mann-Whitney U test, and Kruskal-Wallis H test. Results:The mean age of the patients was 55.5±11.8 and 57.1% of them were female. The clinical diagnosis of the patients were most frequently breast cancer (n=46), colorectal cancer (n=45), and lung cancer (n=25). Furthermore, 37.5% of the patients were in clinical stage II; 15.8% of the patients received paclitaxel+herceptin and 14.1% received gemcitabine+cisplatin chemotherapy protocols. Data demonstrated significant differences in mean scores (p<0.05) taken from "Decline in Basic Taste" and "Phantogeusia and Parageusia" subscales with patients with or without xerostomia. There were significant differences in the average scores of the subscales between those with and without a sore mouth "Discomfort" and "General taste alterations" (p<0.05). Conclusion:It has been established that patients receiving chemotherapy experience substantial alteration in taste by exposure of different subscales of CiTAS. Analysis of scores collected from different subscales of CiTAS with respect to sociodemographic and pathological differences showed that patients with xerostomia and sore mouth experienced more severe taste alterations.

show abstract

“…Tat Alma Bozukluğunun Tipleri Disguzi: Tat alma yeteneğinde bozulma (1,34) Hiperguzi: Tat alma yeteneğinde artma (1,34) Hipoguzi: Tat alma yeteneğinde azalma (1,34) Aguzi: Tat alma fonksiyonunun tamamen kaybı (1,34) Fantoguzi: Genellikle eksternal bir uyarıcı olmadan ağızda acı ya da metalik gibi anormal tat varlığı (34) Paraguzi: Tatları olduğundan farklı algılama (1,34) Kakoguzi: Yiyecek ve içeceklerden kaynaklanmayan hoş olmayan tat (1,34)…”

Section: Hsp 2018;5 (2):259-266unclassified

“…Kemoterapiye bağlı yiyecek tercihinde bireysel farklılıklar olduğu bildirilmiştir (30,32,38,39 (28,33,-34,43), stres ve depresyon (3), ağız kuruluğu (28,33,34,43), hastanede kalma süresinin uzaması (9, 26,28,43), koku almada bozukluk, immün sistemde bozulma (9,26,28) ve tedavi rejimine uyumda azalma (9,18,20,26,28) gelişmektedir.…”

Section: Tat Alma Değişikliğinin Etkileriunclassified

Kanserli Hastalarda Tat Alma Değişikliği

Bılsın¹,

Yılmaz²

2018

Sağlık Bilimleri Ve Meslekleri Dergisi

View full text Add to dashboard Cite

ÖZ Tat alma değişikliği kanserli hastalarda görülen en yaygın ve önemli sorunlardan bir tanesidir. Hastalar tat alma değişimini ağızda metalik, acı ya da kötü bir tat, hassasiyet, tatlıya karşı duyarsızlık ve acıya intolerans olarak tanımlamıştır. Kanserli hastalarda tat alma değişikliğinin nedeni tam olarak bilinmemektedir. Kanser tedavisi fizyolojik ve psikolojik nedenlerle tat almayı etkilemektedir. Kanserli hastalarda tat alma değişikliği sonucunda iştah kaybı, bazı yiyeceklerden hoşlanmama, yiyecek tercihinde değişme, yetersiz beslenme, yetersiz enerji alımı, kilo kaybı, malnutrisyon, kötü prognoz, yaşam kalitesinde azalma, stres, depresyon, ağız kuruluğu, hastanede kalma süresinin uzaması, koku almada bozukluk, immün sistemde bozulma ve tedaviye uyumda bozulma gelişmektedir. Tat alma değişikliğini değerlendirmek ve tedavi etmek zordur. Tat alma değişikliğini tanımlamak, sınıflandırmak ve bu sorunları yönetmek için kanıta dayalı destekleyici stratejilerde yetersizlik olduğu ve profilaktik tedavilerin başarılı olmadığı belirlenmiştir Bu nedenle kanserli hastaların bakım ve tedavisinde tat alma değişikliği yönetimi bir sorun olmaya devam etmektedir.Anahtar kelimeler: Kanser, tat alma değişikliği, hemşirelik ABSTRACT Taste alteration is one of the most common and important problems in patients with cancer. Some patients were defined taste alteration as metallic, bitter or bad taste in the mouth, sensitivity, insensitivity to sweet taste and bitter taste intolerance. The etiologies of taste alteration are not fully known in patients with cancer. Cancer treatment is influenced taste alteration by physiological and psychological causes. In patients with cancer, loss of appetite, dislike of some foods, change in food preferences, inadequate feeding, inadequate energy intake, weight loss, malnutrition, poor prognosis, reduced quality of life, stress, depression, dryness of the mouth, prolonged hospital stay, impaired smell, deterioration of the immune system and reduction compliance to treatment regimen develops as a result of taste alteration. Taste alteration are difficult to measure and treat. It has been determined that there is a lack of supportive strategies based on evidence taste alteration to describe, classify and manage these problems. It has been determined that prophylactic treatments are not successful. For this reason, the management of taste alteration remains a problem in care and treatment of patients with cancer.

show abstract

Development and Validation of a Chemotherapy-Induced Taste Alteration Scale

Abstract: The CiTAS may help evaluate the effectiveness of interventions to reduce the symptoms of taste alterations, such as administering zinc and self-care strategies.

Cited by 73 publications

References 15 publications

Metallic Taste in Cancer Patients Treated with Systemic Therapy: A Questionnaire-based Study

Metallic Taste in Cancer Patients Treated with Systemic Therapy: A Questionnaire-based Study

Taste Alteration in Patients Receiving Chemotherapy

Kanserli Hastalarda Tat Alma Değişikliği

Contact Info

Product

Resources

About